1,481 results
·
17ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·RESOLUTE INTEGRITY ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEMS
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·XIENCE V/nano Everolimus Eluting Coronary Stent System
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·CYPHER SIROLIMUS-ELUTING CORONARY STENT ON RAPTOR OTW DELIVERY SYSTEM/RAPTORRAIL RAPID EXCHANGE DELIVERY SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·Resolute Onyx Zotarolimus-Eluting Coronary Stent Systems, Onyx Frontier Zotarolimus-Eluting Coronary Stent Systems
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·PROMUS PREMIER & PROMUS ELEMENT PLUS EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEMS
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ION PACLITAXEL- ELUTING CORONARY STENT SYSTEM (MONORAIL AND OVER-THE-WIRE SYSTEMS)
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·XIENCE V Everolimus Eluting Coronary Stent System, XIENCE nano Everolimus Eluting Coronary Stent System
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·HER2 CISH PHARMDX KIT
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·XIENCE V AND XIENCE NANO EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·INFORM HER-2 DUAL ISH DNA PROBE COCKTAIL
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·SYNERGY XD and SYNERGY MEGATRON Everolimus-Eluting Platinum Chromium Coronary Stent System
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM (MONORAIL)
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·PROMUS Everolimus-Eluting Coronary Stent System
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS EXPRESS PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·INFORM HER2 Dual ISH DNA Probe Cocktail